Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_assertion type Assertion NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_head.
- NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_assertion wasGeneratedBy ECO_0000203 NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_provenance.
- NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_assertion wasDerivedFrom befree-20150227 NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_provenance.
- NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_assertion SIO_000772 23276366 NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_provenance.
- NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_assertion evidence source_evidence_literature NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_provenance.
- NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_assertion description "[The RAF inhibitors vemurafenib and dabrafenib are emerging as the standard of care for Val600 BRAF-mutant metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664519.RAF_Zb9xifk8mU0OAGMsR4Sh8b8tLp0hcnQpEntDTemGs130_provenance.